Wayne Weisman serves as Executive at Recro Pharma, Inc., where they oversee executive responsibilities. Since joining the company, Wayne Weisman has executed 60 insider transactions totaling $2.7M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 27, 2015 involved selling 6,737 shares valued at $60.6K.
Wayne Weisman currently holds 73,620 shares of Recro Pharma, Inc. (REPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Wayne Weisman has been a net seller of REPH stock. They have purchased $93.7K and sold $2.6M worth of shares.
Wayne Weisman's most recent insider trade was on Nov 27, 2015, when they sold 6,737 shares at $9.00 per share.
Get notified when new Form 4 filings are submitted
| $9.00 |
| Discretionary |
| Nov 25, 2015 | REPH | $14.0K | Sale | 1,553 | $9.00 | Discretionary |
| Nov 25, 2015 | REPH | $41.8K | Sale | 4,648 | $9.00 | Discretionary |
| Nov 24, 2015 | REPH | $6.2K | Sale | 691 | $9.01 | Discretionary |
| Nov 24, 2015 | REPH | $18.6K | Sale | 2,068 | $9.01 | Discretionary |
| Nov 23, 2015 | REPH | $33.3K | Sale | 3,702 | $9.00 | Discretionary |
| Nov 23, 2015 | REPH | $99.7K | Sale | 11,082 | $9.00 | Discretionary |
| Mar 12, 2014 | REPH | $0 | Conversion | 1,121,548 | $N/A | Discretionary |
| Mar 12, 2014 | REPH | $0 | Conversion | 2,045,738 | $N/A | Discretionary |